4.-SINDROME DE HELLP.-/4.-HELLP SYNDROME.-
Es una complicación del embarazo ,usualmente de gestantes con preeclampsia , se presenta en el 20% de preeclampsia severa ,cursa con alta mortalidad materna y fetal ,su acrónimo en ingles
H.-hemolisis,
EL.-enzimas hepáticas elevadas
LP.-plaquetas bajas
su incidencia es mayor con abruptio placentae, preeclampsia severa, incluye CID
TAC:HEMATOMA SUBCAPSULAR POR SINDROME DE HELLP(HEMOLISIS, AUMENTO DE ENZIMAS HEPÁTICAS, CUENTA PLAQUETARIA BAJA.
1-La mortalidad perinatal es tan alta como 60%
2.-Se asocia prematurez y RCIU
3.-No hay síntomas específicos (se asocia con preeclampsia )
4.-La cuenta plaquetaria es el indicador más confiable de este sindrome
5.-.El tratamiento es profilaxis de convulsiones, control de presión arterial , corrección de alteraciones hematológicos como plaquetopenia,transfusion de plaquetas y terminar la gestación de emergencia
6.-se usan dosis altas de dexametasona , betametasona en dos dosis de 12mg con 12 horas de diferencia
7.-la morbilidad y mortalidad materna es de 25%
8.-Ato(se asocia con preeclampsia severa nia uterina y CID (Coagulacion Intravascular Diseminada) hematuriaIt is a complication of pregnancy, usually of pregnant women with preeclampsia, it occurs in 20% of severe preeclampsia, it presents with high maternal and fetal mortality, its acronym in English
H.-hemolysis,
EL.-elevated liver enzymes
LP.-low platelets
its incidence is higher with abruptio placentae, severe preeclampsia, includes DIC
CT: SUBCAPSULAR HEMATOMA DUE TO HELLP SYNDROME (HEMOLISIS, INCREASED LIVER ENZYMES, LOW PLATELET COUNT.
1-Perinatal mortality is as high as 60%
2.-Prematurity and IUGR are associated
3.-No specific symptoms (associated with preeclampsia)
4.-The platelet count is the most reliable indicator of this syndrome
5.-.The treatment is seizure prophylaxis, blood pressure control, correction of hematological alterations such as thrombocytopenia, platelet transfusion and emergency termination of pregnancy.
6.-high doses of dexamethasone are used, betamethasone in two doses of 12mg 12 hours apart
7.-maternal morbidity and mortality is 25%
8.-Ato (associated with severe uterine preeclampsia and DIC (Disseminated Intravascular Coagulation) hematuria
No hay comentarios:
Publicar un comentario